Prevention of fractures in patients with osteoporosis

Affiliations

Comment

Serge Livio Ferrari. Lancet. 2018.

. 2018 Jan 20;391(10117):184-186.

doi: 10.1016/S0140-6736(17)32167-0. Epub 2017 Nov 9.

¹ Service and Laboratory of Bone Diseases, Geneva University Hospital, 1205 Geneva, Switzerland. Electronic address: serge.ferrari@unige.ch.

No abstract available

Comment on

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
Kendler DL, Marin F, Zerbini CAF, Russo LA, Greenspan SL, Zikan V, Bagur A, Malouf-Sierra J, Lakatos P, Fahrleitner-Pammer A, Lespessailles E, Minisola S, Body JJ, Geusens P, Möricke R, López-Romero P. Kendler DL, et al. Lancet. 2018 Jan 20;391(10117):230-240. doi: 10.1016/S0140-6736(17)32137-2. Epub 2017 Nov 9. Lancet. 2018. PMID: 29129436 Clinical Trial.